Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes.

However another study where ticagrelor continued until the last day prior to surgery demonstrated a clear trend towards a higher incidence of major bleeding [ 27 ].

also in 19,460 other papers